Try our Advanced Search for more refined results

Expert Analysis - Opinion

High Court Should Review Horizon Arthritis Drug Patent Case

By Paul Michel and John Battaglia (September 8, 2020, 12:24 PM EDT) -- So much patent-law attention today focuses on Title 35 of the U.S. Code, Section 101, and the ever-emerging ineligibility case law, and perhaps rightly so. The problem arises when another legal basic gets lost in the judicial shuffle, risking damage to core patent rights and doctrine if left uncorrected. And that is a primary reason why, in our view, the U.S. Supreme Court should grant certiorari in HZNP Medicines LLC v. Actavis Laboratories UT Inc.[1]...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!